Femme et Homme
- | Pays :
- Slovakia
- Italy
- Czech Republic
- Les 12 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to compare the time to progression (TTP) of three daily doses of thalidomide (100, 200 and 400 mg) with high-dose dexamethasone in relapsed refractory multiple myeloma (MM) patients and to subsequently select the optimum thalidomide dose in terms of median TPP and toxicity.
Critère d'inclusion
- Multiple myeloma